Related Experiment Video
Updated: Oct 19, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Mild Cognitive Impairment: Diagnosis and Subtypes
15396St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
Abstract:
Mild cognitive impairment (MCI) is a clinical diagnosis based on subjective cognitive decline, objective cognitive impairment, and relative preservation of activities of daily living. The diagnosis may be established via clinical interview, collateral history from an informant, and psychometric examination. Various consensus groups have proposed criteria for MCI in Alzheimer's disease (AD), Parkinson's disease, dementia with Lewy bodies, and vascular cognitive impairment. These diagnostic criteria have subtle but important differences. Criteria for subjective decline vary according to whether memory is impaired or whether impairment in any cognitive domain is sufficient. There are also differences with respect to whether the subjective decline is noted by the patient, a carer, or a clinician. The precise thresholds for classifying objective cognitive impairment also vary between various diagnostic criteria. There are also differences in the description of functional abilities. Once established, the diagnosis of MCI may be refined to 1 of 4 subtypes based on the pattern of cognitive impairment. The 4 subtypes are defined according to whether or not memory is impaired and whether 1 or more cognitive domains are impaired. Once a diagnosis of MCI has been made, the patient and the family should be counseled about social and legal implications as well as strategies for reducing the risk of progression to dementia. The main utilities of MCI as a nosology are to understand the natural history of neurodegenerative disorders such as AD, to identify those at increased risk of progressing to develop dementia, and to identifying individuals for putative treatments.
Insights
Mild cognitive impairment (MCI) is diagnosed using cognitive assessments and impacts daily living. Understanding MCI subtypes aids in predicting dementia risk and identifying individuals for potential treatments.
Area of Science:
- Neurology
- Gerontology
- Psychiatry
Background:
- Mild cognitive impairment (MCI) is a clinical diagnosis.
- It involves subjective cognitive decline and objective impairment with preserved daily function.
- MCI diagnosis is established through clinical interviews, informant history, and psychometric testing.
Purpose of the Study:
- To review diagnostic criteria for MCI across various neurodegenerative conditions.
- To highlight variations in criteria for subjective decline, cognitive impairment, and functional abilities.
- To outline the classification of MCI into subtypes and discuss its clinical utility.
Main Methods:
- Review of consensus group criteria for MCI in Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, and vascular cognitive impairment.
- Analysis of differences in criteria for subjective cognitive decline, objective impairment thresholds, and functional descriptions.
- Examination of MCI subtypes based on cognitive impairment patterns.
Main Results:
- Diagnostic criteria for MCI exhibit subtle but significant differences among consensus groups.
- Variations exist in defining subjective decline, objective impairment, and functional preservation.
- MCI can be classified into four subtypes based on memory and domain impairment patterns.
Conclusions:
- Standardizing MCI diagnostic criteria is crucial for consistent clinical application.
- Understanding MCI subtypes aids in predicting progression to dementia.
- MCI serves as a critical nosology for studying neurodegenerative disease progression and identifying treatment candidates.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
07:30Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Related Concept Videos
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Intellectual Disability
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive Development During Adulthood
Alzheimer's Disease: Treatment